Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Society for Medical Oncology (ESMO) 2021 annual meeting was held virtually this year between 16-21 September and showcased the very latest advances in the treatment of cancer. Catch up on key trial updates including results from the practice-changing PEACE-1, and DESTINY-Breast03 studies as well as our in-person roundtable discussions on the most important data.

ESMO 2021

16–21 September 2021 | Virtual Meeting
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 1 Like on Twitter 1780906710992842782 3 Twitter 1780906710992842782
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780884364898767226

🌟We are delighted to be in Belfast for #BTOG24 @BTOGORG

We're looking forward to catching up with leading experts to talk all things #lungcancer for the UK!

Keep an eye on http://VJOncology.com for updates

🎥We're on level 2 by the escalator, come and say hi!

Image for the Tweet beginning: 🌟We are delighted to be Twitter feed image.
Reply on Twitter 1780884364898767226 Retweet on Twitter 1780884364898767226 0 Like on Twitter 1780884364898767226 2 Twitter 1780884364898767226
VJOncology avatar; VJ Oncology @VJOncology ·
April 16, 2024 1780159332660679082

April is #BowelCancer Awareness Month 📣

We have a #GICancer podcast! Take a look at the latest episodes from #ASCOGI 2024🎧👇

🌟Highlights in #colorectalcancer 👉 https://www.vjoncology.com/podcast/highlights-in-colorectal-cancer-at-asco-gi-2024/

🌟 #Esophageal & #gastriccancer highlights 👉 https://www.vjoncology.com/podcast/esophageal-and-gastric-cancer-highlights-from-asco-gi-2024/

#CRCsm

Image for the Tweet beginning: April is #BowelCancer Awareness Month Twitter feed image.
Reply on Twitter 1780159332660679082 Retweet on Twitter 1780159332660679082 0 Like on Twitter 1780159332660679082 3 Twitter 1780159332660679082
Load More

ESMO 2021

16–21 September 2021 | Virtual Meeting
The European Society for Medical Oncology (ESMO) 2021 annual meeting was held virtually this year between 16-21 September and showcased the very latest advances in the treatment of cancer. Catch up on key trial updates including results from the practice-changing PEACE-1, and DESTINY-Breast03 studies as well as our in-person roundtable discussions on the most important data.
View all videos
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780906710992842782

🎥We had the pleasure of catching up with @AdamJanuszewski this morning to discuss the BTOG Therapeutics Symposium, ADCs in #lungcancer, and more at #BTOG24

👀Interview coming soon to http://VJOncology.com

@BTOGORG #LCSM #NSCLC #SCLC #LungCancer

Image for the Tweet beginning: 🎥We had the pleasure of Twitter feed image.
Reply on Twitter 1780906710992842782 Retweet on Twitter 1780906710992842782 1 Like on Twitter 1780906710992842782 3 Twitter 1780906710992842782
VJOncology avatar; VJ Oncology @VJOncology ·
April 18, 2024 1780884364898767226

🌟We are delighted to be in Belfast for #BTOG24 @BTOGORG

We're looking forward to catching up with leading experts to talk all things #lungcancer for the UK!

Keep an eye on http://VJOncology.com for updates

🎥We're on level 2 by the escalator, come and say hi!

Image for the Tweet beginning: 🌟We are delighted to be Twitter feed image.
Reply on Twitter 1780884364898767226 Retweet on Twitter 1780884364898767226 0 Like on Twitter 1780884364898767226 2 Twitter 1780884364898767226
VJOncology avatar; VJ Oncology @VJOncology ·
April 16, 2024 1780159332660679082

April is #BowelCancer Awareness Month 📣

We have a #GICancer podcast! Take a look at the latest episodes from #ASCOGI 2024🎧👇

🌟Highlights in #colorectalcancer 👉 https://www.vjoncology.com/podcast/highlights-in-colorectal-cancer-at-asco-gi-2024/

🌟 #Esophageal & #gastriccancer highlights 👉 https://www.vjoncology.com/podcast/esophageal-and-gastric-cancer-highlights-from-asco-gi-2024/

#CRCsm

Image for the Tweet beginning: April is #BowelCancer Awareness Month Twitter feed image.
Reply on Twitter 1780159332660679082 Retweet on Twitter 1780159332660679082 0 Like on Twitter 1780159332660679082 3 Twitter 1780159332660679082
Load More

Latest Videos from ESMO 2021

View all
2:23
Highlights in glioblastoma at ESMO 2022
Maximilian Mair • 12 Sep 2022
6:27
ESMO highlights: methylation-based MCED and the predictive role of ctDNA in uveal melanoma
Christian Rolfo • 20 Sep 2021
1:40
ESMO: Young Oncologists Track
Claudia Cardone • 19 Sep 2021
5:28
Importance of real-world data in clinical trials
Janet E. Brown • 19 Sep 2021

Live in Paris from ESMO 2021

View all
1:40
ESMO: Young Oncologists Track
Claudia Cardone • 19 Sep 2021
5:28
Importance of real-world data in clinical trials
Janet E. Brown • 19 Sep 2021
2:21
PRISM: importance of investigating the scheduling of treatment regimens for RCC
Janet E. Brown • 19 Sep 2021
0:53
Treatments for patients with NSCLC carrying EGFR exon 20 insertions
Robin Cornelissen • 18 Sep 2021

Breast Cancer at ESMO 2021

View all
2:06
NGS multi-panel gene testing for newly diagnosed patients with metastatic breast cancer
Evandro de Azambuja • 18 Sep 2021
4:40
AMEERA-1 updates: amcenestrant plus palbociclib for patients with ER+/HER2– advanced breast cancer
Mario Campone • 30 Sep 2021
2:46
Prognostic impact of immune interactions in patients with HER2+ and TNBC with brain metastases
Gaia Griguolo • 21 Sep 2021
2:38
HER2+ and TNBC highlights from ESMO 2021
Gaia Griguolo • 21 Sep 2021

Skin Cancer at ESMO 2021

View all
6:27
ESMO highlights: methylation-based MCED and the predictive role of ctDNA in uveal melanoma
Christian Rolfo • 20 Sep 2021
1:36
Results from KEYNOTE-716: adjuvant therapy with pembrolizumab in high-risk stage II melanoma
Thomas Eigentler • 27 Sep 2021
5:54
KEYNOTE-716: adjuvant therapy with pembrolizumab for patients with high-risk stage II melanoma
Omid Hamid • 27 Sep 2021
5:01
Melanoma highlights from ESMO 2021
Omid Hamid • 27 Sep 2021

Genitourinary Cancer at ESMO 2021

View all
3:42
NORSE: erdafitinib + cetrelimab in mUC with FGFR alterations
Thomas Powles • 18 Sep 2021
3:09
Prostate cancer updates at ESMO 2021: STAMPEDE and PEACE-1
Silke Gillessen • 17 Sep 2021
3:58
Pembrolizumab in combination with sEphB4-HSA (B4) in previously treated mUC
Enrique Grande • 17 Sep 2021
6:12
Neoadjuvant enoblituzumab for localized prostate cancer
Eugene Shenderov • 17 Sep 2021
The content of VJOncology is intended for healthcare professionals